Skip to Content

Mylan Receives FDA OK for Lithium Carbonate Dose

From Associated Press (August 10, 2012)

CANONSBURG, Pa. -- Generic drug maker Mylan Inc. said Friday it received Food and Drug Administration approval for another version of Lithobid, a treatment for manic episodes of manic depressive illness.

The Canonsburg, Pa., company said it received approval for 450-milligram lithium carbonate extended-release tablets, and it will start selling them immediately. The treatment had U.S. sales of about $15.2 million in the year that ended June 30.

Last month, Mylan started selling 300-milligram tablets of lithium carbonate.

Mylan’s stock was unchanged in premarket trading.

Posted: August 2012